Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-17
DOI
10.3389/fimmu.2021.832942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer
- (2021) Na Wang et al. DRUG DELIVERY
- Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune‐Based Combination Therapy
- (2021) Hongyu Ma et al. MACROMOLECULAR BIOSCIENCE
- A Checkpoint‐Regulatable Immune Niche Created by Injectable Hydrogel for Tumor Therapy
- (2021) Qian Li et al. ADVANCED FUNCTIONAL MATERIALS
- Peptide hydrogels loaded with irradiated tumor cell secretions enhance cancer immunotherapy
- (2021) Chao Wan et al. Nano Today
- Peri-tumor administration of controlled release anti-CTLA-4 synergizes with systemic anti-PD-1 to induce systemic antitumor immunity while sparing autoimmune toxicity
- (2020) Airi Harui et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
- (2020) Feihu Wang et al. Science Advances
- Advances and trends of hydrogel therapy platform in localized tumor treatment: a review
- (2020) Bowen Tan et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies
- (2020) Chih Kit Chung et al. JOURNAL OF CONTROLLED RELEASE
- Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
- (2020) Yajie Sun et al. Asian Journal of Pharmaceutical Sciences
- Injectable biodegradation-visual self-healing citrate hydrogel with high tissue penetration for microenvironment-responsive degradation and local tumor therapy
- (2020) Min Wang et al. BIOMATERIALS
- Targeting immunogenic cell death in cancer
- (2020) Asma Ahmed et al. Molecular Oncology
- Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
- (2019) Caifeng Deng et al. Advanced Science
- Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
- (2019) Daisuke Muraoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
- (2019) John D. Martin et al. Annual Review of Physiology
- A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade
- (2019) Huitong Ruan et al. ADVANCED MATERIALS
- Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer
- (2019) Marziyeh Fathi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Smart Injectable Hydrogels for Cancer Immunotherapy
- (2019) Yu Chao et al. ADVANCED FUNCTIONAL MATERIALS
- Progress on Modulating Tumor‐Associated Macrophages with Biomaterials
- (2019) Meilyn Sylvestre et al. ADVANCED MATERIALS
- Repolarization of M2 to M1 Macrophages Triggered by Lactate Oxidase Released from Methylcellulose Hydrogel
- (2019) Zi-Xian Liao et al. BIOCONJUGATE CHEMISTRY
- Inhibition of breast cancer proliferation and metastasis by strengthening host immunity with a prolonged oxygen-generating phototherapy hydrogel
- (2019) Tian-Jiao Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Extravascular gelation shrinkage-derived internal stress enables tumor starvation therapy with suppressed metastasis and recurrence
- (2019) Kun Zhang et al. Nature Communications
- A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism
- (2019) Sanjay Pal et al. ACS Central Science
- Injectable Hydrogels for Localized Cancer Therapy
- (2019) Dao-yang Fan et al. Frontiers in Chemistry
- Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy
- (2019) Xia Dong et al. BIOMATERIALS
- Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
- (2018) Honglin Jin et al. ACS Nano
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Diverse Functions of Macrophages in Different Tumor Microenvironments
- (2018) Ming Yang et al. CANCER RESEARCH
- Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
- (2018) Sara Musetti et al. ACS Nano
- Injectable Hydrogels as Unique Platforms for Local Chemotherapeutics-Based Combination Antitumor Therapy
- (2018) Shuangjiang Yu et al. MACROMOLECULAR BIOSCIENCE
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy
- (2017) Natália N. Ferreira et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ipilimumab: from preclinical development to future clinical perspectives in melanoma
- (2017) Paul Letendre et al. Future Oncology
- Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy
- (2017) Eonju Oh et al. JOURNAL OF CONTROLLED RELEASE
- Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis
- (2017) Peiwen Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting tumor associated macrophages: The new challenge for nanomedicine
- (2017) Fernando Torres Andón et al. SEMINARS IN IMMUNOLOGY
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
- (2017) Guangbao Yang et al. Nature Communications
- Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model
- (2017) Chanju Lee et al. Oncotarget
- The Anti-Tumor Effects of M1 Macrophage-Loaded Poly (ethylene glycol) and Gelatin-Based Hydrogels on Hepatocellular Carcinoma
- (2017) Alberto Daniel Guerra et al. Theranostics
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Injectable hydrogel-based drug delivery systems for local cancer therapy
- (2016) Mohammad Norouzi et al. DRUG DISCOVERY TODAY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
- (2015) Oscar W.H. Yeung et al. JOURNAL OF HEPATOLOGY
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
- (2015) Yongkui Li et al. OncoImmunology
- The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
- (2015) Kosuke Mizutani et al. NEOPLASIA
- Hydrogels and Scaffolds for Immunomodulation
- (2014) Ankur Singh et al. ADVANCED MATERIALS
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment
- (2014) Hidetaka Fujii et al. CANCER SCIENCE
- Synergistic dual-targeting hydrogel improves targeting and anticancer effect of Taxol in vitro and in vivo
- (2014) Chang Shu et al. CHEMICAL COMMUNICATIONS
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy
- (2013) Keming Xu et al. JOURNAL OF CONTROLLED RELEASE
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
- (2012) Alberto Gulino International Journal of Nanomedicine
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Designing Cell-Compatible Hydrogels for Biomedical Applications
- (2012) D. Seliktar SCIENCE
- Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
- (2011) D. A. Hume et al. BLOOD
- Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications
- (2011) Yulin Li et al. CHEMICAL SOCIETY REVIEWS
- Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy
- (2011) Marc Baay et al. Clinical & Developmental Immunology
- Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma
- (2011) Amir S. Gendy et al. JOURNAL OF PEDIATRIC SURGERY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
- (2010) Mingli Xu et al. Clinical & Developmental Immunology
- Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells
- (2010) Lorna Rettig et al. INTERNATIONAL JOURNAL OF CANCER
- Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity
- (2008) Soo Hong Seo et al. CLINICAL & EXPERIMENTAL METASTASIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now